JAK2 and myeloproliferative disorder: Although the mTORC1 activity has been reported to be upregulated in primary MPN cells with its inhibition leading to suppression of cell proliferation [6, 15–17], its activation mechanisms have not precisely been elucidated with its possible relationship with the STAT5 pathway activated by JAK2-V617F unknown.